Popping up today,
shaping tomorrow.

Empowering Visionaries in Healthcare

Innovators Pop-Up was born out of the idea that early innovators need a space dedicated to showcasing their technology that allows for connection with key industry influencers, provides a compelling and memorable experience for attendees, and delivers enduring impact.

Empowering Visionaries in HealthcarE

Innovators Pop-Up was born out of the idea that early innovators need a space dedicated to showcasing their technology that allows for connection with key industry influencers, provides a compelling and memorable experience for attendees, and delivers enduring impact.

Havana Nights

Orlando, FL

Thank you for joining us at the 2025 Innovators Pop-Up in Orlando.

Stay tuned to see where we’ll be popping up next!

9101 International Dr, Orlando, FL 32819

INNOVATION AND ADVENTURE PROMISED

Be the first to know and subscribe to our newsletter!

Sign Up!
REGISTER!

JOIN US IN THE INNOVATION SHOWCASE

This dynamic and immersive event will showcase cutting-edge healthcare innovations in an interactive “playground.” Dive into a world where groundbreaking ophthalmology meets hands-on exploration, fostering connections and sparking revolutionary ideas.

Get HANDS-ON with the
latest technologies in
ophthalmology

Connect with industry
leaders and fellow
visionaries

Cheer on innovators as they step into the Hot Seat — where they’ll face rapid-fire questions from industry leaders and compete to be named the top innovator of the night.

Be part of shaping the
next wave of ophthalmic
advancements

ready to showcase
your healthcare technology?

INNOVATOR

What People are Saying About Pop-Up

Insights, takeaways, and standout moments—straight from our attendees.

“As someone who enjoys working with early-stage companies and research I loved this event. This was a perfect opportunity to have the entire ophthalmic community in one room to help push through innovation.”
-William Wiley, MD, Cleveland Eye Clinic
“A big THANK YOU for having Oculotix at the Innovator’s Pop Up. We got some great connections from it and a valuable opportunity to practice our pitch. And it was also a lot of fun!”
- Shravanthi Reddy, PhD, CEO of Oculotix
“The most valuable part of participating in this is interacting with people in a very natural way and introducing your products so they get a chance to touch and feel them. It’s nice to be able to sit and chat in a fun atmosphere with music. People came here to have fun, to learn something, and to really enjoy themselves.”
- John Garland, Consultant
The part about Innovators Pop-up that exceeded my expectations is introducing the ability to interact with the technology, not just hear about it in a didactic way. I think innovators need this type of pop-up opportunity to showcase all the work that they've put in - oftentimes years of work - and if you're doing it with people who are interested in early-stage innovation, then you're able to showcase that in a really meaningful and, frankly, fun way. That attracts the right people and the right type of dialogue that we're all hoping for."
- Sanjeev Ganatra, Global Head, Ophthalmology, CBCC Global Research

Celebrating Past Showcase Innovators

Innovation Partners from Previous Pop-Ups

Sponsors Through the Years

Want to support the innovator ecosystem?

Sponsor

Powered By:

Stay in the Pop-Up Loop!

Pop into our exclusive email list and be the first to know where Innovators Pop-Up will pop up next. It’s like a surprise party for your inbox – but way cooler.

© 2026 Innovators Pop-up. All rights reserved.
Linkedin-in

Atia Vision

BIO

Atia Vision, a Shifamed portfolio company, is developing a next-generation technology for cataract surgery with its OmniVu™ Lens System, a dual-optic presbyopia-correcting intraocular lens technology. This system is designed to:  

– Deliver refractive predictability – Provide continuous vision across a broad range of defocus

– Preserve natural image quality while minimizing visual disturbances – Stabilize intraocular structures and promote capsular bag health

– Preserve future options for surgeons and patients through its modular, adaptable platform  

The OmniVu™ Lens System combines a fixed power front optic made from hydrophobic acrylic with a fluid-filled, shape-changing base made from silicone. This design is based on learnings from prior generation technologies and aims to address gaps in current solutions, with the goal of providing improved visual outcomes while maintaining long-term stability and flexibility.

EyeCool Therapeutics

https://eyecooltx.com/

EyeCool is developing a revolutionary treatment for Chronic Ocular Surface Pain (COSP). Our device is designed to deliver a targeted, precise dose of thermal energy to transform the experience of COSP patients.

eyejourney by Innoptix

innoptix.com/eyejourney

eyejourney by Innoptix streamlines the patient journey by automating reminders, checklists, and medication tracking, improving patient engagement while delivering valuable benefits for clinics.

GreenMan Vision, Inc.

https://greenmanvr.com/

At Greenman, we are transforming cataract education using cutting edge technology. By turning complex medical decisions into clear, experience-driven choices, we’re empowering patients to take control of their vision health with confidence and strengthening surgeon-patient communication by fostering informed dialogue.

Our virtual reality technology, the InSightVR system, allows patients to visualize their post-surgical outcomes before making a decision. This sets realistic expectations, improves decision-making, and fosters trust.

Myra Vision

BIO

Seeking to answer the need for personalized glaucoma care, Myra Vision is developing the Calibreye™ Titratable Glaucoma TherapyTM (TGT) Surgical System—the next-generation solution designed for patients with glaucoma who require low intraocular pressure (IOP).

The Calibreye TGT Surgical System aims to:

  • Personalize glaucoma care by enabling adjustable outflow control
  • Provide a safe solution to IOP reduction by using biocompatible materials that conform to the eye
  • Enhance the confidence of ophthalmologists during implantation, by leveraging the well-established method of ab externo delivery
  • Reverse hypotony due to excessive flow with an adjustable feature built into its innovative design


As an unprecedented development in glaucoma care, the Calibreye TGT System is designed to improve outcomes and minimize complications associated with conventional approaches.

The Calibreye TGT Surgical System is for investigational use only and is not for sale in the US or outside the US.

NuLids

BIO

NuLiDS is an innovative eyelid care technology developed by John Olkowski, MD, a board-certified ophthalmologist and corneal specialist. Dr. Olkowski recognized the central role of eyelid care in ocular health and developed the safe, effective, and convenient NuLIDS to proactively manage common, under-diagnosed conditions like dry eye. The San Diego-based company has sold 25,000 “At Home” units and recently introduced the “PRO” in-practice version of NuLIDS globally.

NuLIDS is a small handheld electromechanical device which operates by low-speed oscillation utilizing single use disposable silicon tips. The comfortable 1-2 minute vibrating treatment is performed on a closed eye to (1) clean the eyelids and eyelashes, (2) massage the eyelids to enhance meibomian gland production and (3) remove demodex mites. With increased recognition of proactive ocular wellness, NuLIDS is uniquely positioned to enable convenient and affordable high quality lid hygiene in the office and at home.

Oculotix

BIO

Oculotix is applying AI-based software to optimize intraocular lens (IOL) model selection to improve patient vision outcomes and boost surgical efficiency in cataract and lens exchange procedures. The software provides surgeons with predictive analytics of vision outcomes and a recommended IOL model to achieve the best possible outcome for their patients.

Vision outcomes are predicted and compared to the patient’s expectations for day/night driving, spectacle-independence, and potential visual artifacts. This information provides the surgeon and patient with a quantitative pre-operative assessment, increasing the likelihood of patient satisfaction with surgical outcomes while also saving clinical time and resources. The software is particularly useful in boosting confidence in adoption of advanced technology IOLs, which can have benefits for patients well suited to the technologies available.

Sydnexis

https://sydnexis.com/

Sydnexis is a a privately-held, clinical stage biopharmaceutical company based in San Diego. Sydnexis is currently awaiting PDUFA approval at FDA for its patented eyedrop formulation, SYD-101, a low-dose atropine eye drop engineered specifically for growing eyes. It is being studied in children as young as 3 as a potential pharmaceutical treatment for progressive pediatric myopia. Our landmark STAR study — the largest and most comprehensive of its kind — has generated rigorous long-term data to help establish a safe, consistent solution to one of the most urgent unmet needs in pediatric ophthalmology.

TECLens

https://teclens.com/

At TECLens, we’re dedicated to restoring vision and improving quality of life for millions of people around the world.

Our innovative treatment utilizes proprietary quantitative corneal cross-linking (qCXL™) technology and the CXLens® device to gently strengthen and reshape the cornea, designed to redefine vision correction for refractive errors, including restoring near vision for those with presbyopia. The procedure aims to be a comfortable, non-invasive, in-office treatments.

TECLens is also exploring future applications for hyperopia, progressive myopia in children and low-order myopia in adults, and keratoconus, promising a brighter future for vision correction.

Osheru

https://www.ziplyft.com/
Osheru is a medical device company that is innovating skin removal with a new technology-compressive skin contouring. Our initial product, the Ziplyft, revolutionizes blepharoplasty (eyelid) surgery by making it faster and easier on the patient and the surgeon without the need for cautery or sutures. The patient benefits by having less bruising and downtime and the surgeon benefits by having an efficient and consistent procedure.

Visionary Ventures

visionaryvc.com

Visionary Ventures is a venture capital fund that partners with KOLs to invest in life sciences and the future of ophthalmology. We are an opportunistic venture fund that invests in early and late stages of a company’s growth, from early-stage Series A rounds in clinical trials to late-stage rounds in commercialization. Our target investment range is $5M to $15M.

Amaros

BIO

https://amaros.ai/

Amaros’ EvidenceEngine™ is an AI-powered platform designed to unify and transform fragmented ophthalmic data into actionable intelligence, revolutionizing clinical development, research, and therapeutic decision-making across the eye care continuum. Built in Silicon Valley and backed by serial ophthalmic entrepreneurs, AI scientists, clinicians, and CRO experts, the platform targets a critical bottleneck in ophthalmology: disconnected datasets that hinder efficient trials, slow adoption of therapies, and limit patient access.

Bausch + Lomb

https://www.bausch.com/

Bausch + Lomb is dedicated to protecting and enhancing the gift of sight for millions of people around the world – from birth through every phase of life. Its comprehensive portfolio of approximately 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments. Founded in 1853, Bausch + Lomb has a significant global research and development, manufacturing and commercial footprint with approximately 13,000 employees and a presence in nearly 100 countries. Bausch + Lomb is headquartered in Vaughan, Ontario, with corporate offices in Bridgewater, New Jersey. For more information, visit www.bausch.com and connect with us on X, LinkedIn, Facebook and Instagram.

BTIG

www.btig.com

BTIG is a global financial services firm specializing in institutional trading, investment banking, research and related brokerage services. With an extensive global footprint and more than 700 employees, BTIG, LLC and its affiliates operate out of 20 cities throughout the U.S., and in Europe, Asia and Australia. BTIG offers execution, expertise and insights for equities, equity derivatives, ETFs and fixed income, currency and commodities. The firm’s core capabilities include global execution, portfolio, electronic and outsource trading, investment banking, prime brokerage, capital introduction, corporate access, research and strategy, commission management and more.

LELU Management

BIO

Lelu Management is a dedicated service provider specializing in healthcare solutions. Our focus is on empowering healthcare organizations with innovative strategies that streamline operations, enhance financial management, and optimize overall efficiency. We partner with industry leaders to offer tailored solutions that meet the unique needs of the healthcare sector, ensuring our clients can focus on delivering high-quality patient care while we handle the rest.

True North

https://truenorthcro.com/

True North Contract Research is a dynamic and rapidly growing Contract Research Organization (CRO) specializing in Ophthalmology research. We strive to deliver an experience that is second to none to our sponsor partners and site partners. Our longstanding commitment to advancing the field of ophthalmology through clinical research has provided us with the experience to execute trials efficiently with a focus on accuracy and compliance. We merge FDA and clinical site perspectives to identify effective solutions that are agreeable to both parties and then mitigate roadblocks to achieve trial endpoints. One of our greatest strengths is uniting with sponsoring companies as a seamless team that makes well-thought-through decisions on time.